Generics

FDA gives Lupin OK for new generic, tentative nod for generic Triumeq

The FDA has given Lupin approval for generic Entresto, and tentative approval for generic Triumeq.
Organizations react to administration's new tariffs

Several organizations, including the National Retail Federation, are weighing in on the impact of the new tariffs on China and Canada.
FDA gives Amneal permission for 2 new generics, tentative OK for generic Xifaxan

The approvals provide therapies for dementia, oncology and gastrointestinal disease.
Glenmark launches generic vitamin K1 injectable emulsion

Vitamin K1 injectable emulsion had a market value of approximately $19.7 million, for the 12 months ending November 2024, per IQVIA.
AAM displeased with Medicare Drug Price Negotiation list

AAM said that by including drugs with generics and biosimilars in development in the 15 drugs selected for negotiation, CMS highlights a central flaw in the IRA price setting scheme.
Somerset Pharma intros 4 generics

Somerset is expanding its generic ophthalmics portfolio.
Alembic intros generic Corlanor

Ivabradine tablets are indicated to reduce the risk of hospitalization for worsening heart failure in adult patients with stable, symptomatic chronic heart failure with reduced left ventricular ejection fraction.
Dr. Marc Siegel to speak at AAM’s Access!2025

Dr. Siegel’s keynote will address critical issues that impact industries and communities—sustainability, shortages and the ripple effects on public health.

AAM: Redesigned Medicare drug program still allows PBMs to deny patients access to lower-cost generics, biosimilars